Regarding the rise and the epidemiological shifts in Candida infections, ac
curate and rapid identification of yeasts to species level is exceedingly i
mportant. Furthermore, non-albicans species (e.g. C. glabrata, C. dublinien
sis, C. inconspicua, C. krusei and C. norvegensis) have recently emerged as
azole-resistant pathogens. Standard methods fbr cultivation and differenti
ation of Candida species are time-consuming, often insensitive and can fail
to distinguish non-albicans species. To overcome low sensitivity, poor spe
cificity and untolerable delay molecular tools to the diagnosis of Candida
infection have been adopted, particularly the polymerase chain reaction (PC
R). Several genus and species specific amplification-based diagnostic metho
ds for detect ion of medically important yeasts have been published. As the
incidence of nosocomial Candida infections has been risen significantly, t
yping has become increasingly important in candidal epidemiology to define
infectious processes as well as soul-ces and modes of transmission. For the
development of rational infection-control measures, modern genotyping meth
ods based on genomic DNA polymorphism (e.g. pulsed-field gel electrophoresi
s, DNA amplification-based methods) have replaced conventional physiologica
l techniques. However, reliability, sensitivity and efficiency of genotypin
g methods have been controversially discussed and these DNA-based methods a
re mostly insufficiently standardized. Criteria as typeability reproducibil
ity and discriminatory power should be considered in evaluating typing syst
ems.